- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03697486
The Effect of Breakfast With Different Macronutrient Composition on PYY, Ghrelin, GLP-1,Glucose Level, VAS for Hunger, VAS for Satiety and Ad Libitum Intake 4 Hours After Breakfast in Obese Women
The Effect of Breakfast With Different Macronutrient Composition on PYY, Ghrelin, GLP-1, Glucose Level, VAS for Hunger, VAS for Satiety and Ad Libitum Intake 4 Hours After Breakfast in Obese Women
Gut hormones, such as PYY and ghrelin, are associated with appetite control and obesity. Protein is thought to be the most satieting nutrient and could affect production of several gut hormones. This study's objective is to find the effect of breakfast with different protein composition on PYY, ghrelin, and ad libitum intake four hours after breakfast.
The research methodology was used a clinical trial with 22 obese women participants. Subjects were given three types of breakfast: low protein consumption (12.4% protein), medium protein (23.5% protein), and high protein (40,6% protein). PYY and ghrelin level were measured at 0, 15, 60, 120, and 180 minutes after breakfast. Ad libitum meal was given four hours after breakfast and measured after.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Jakarta Pusat
-
Jakarta, Jakarta Pusat, Indonesia, 10110
- Departement of Nutrition, Faculty of Medicine Universitas Indonesia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI 25-30 (obese)
- with stable body weight within the last 6 months (body weight change less than 4 kg)
- normal blood glucose level.
Exclusion Criteria:
- patients who never had breakfast
- patients in weight loss program
- patients consuming lipid-absorption inhibitor or appetite-suppressing drugs
- patients that have had gastrointestinal tract resection.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: High Protein
(40,6% protein)
|
Participants should not eat within the last 10 hours. Participants could drink mineral water up to 2 hours before intervention. Breakfast given is a milk-based formula which has to be finished within 15 minutes, and subjects could only consume 600 mL of mineral water within the next 4 hours after intervention. Participants' blood was taken before intervention, and 15, 60, 120, and 180 minutes after intervention, then examined in laboratory to measure ghrelin and PYY level. Breakfast given is adjusted to participants' energy requirement. Energy requirement is calculated by adding basal metabolic rate (BMR) with additional energy from physical activity. Different composition of protein, carbohydrate and fat were given to each arm depends on their group. After 4 hours, participants were given ad libitum meal. After the participants done eating, the calorie in meal taken by participants was measured. |
|
EXPERIMENTAL: Moderate Protein
(23.5% protein)
|
Participants should not eat within the last 10 hours. Participants could drink mineral water up to 2 hours before intervention. Breakfast given is a milk-based formula which has to be finished within 15 minutes, and subjects could only consume 600 mL of mineral water within the next 4 hours after intervention. Participants' blood was taken before intervention, and 15, 60, 120, and 180 minutes after intervention, then examined in laboratory to measure ghrelin and PYY level. Breakfast given is adjusted to participants' energy requirement. Energy requirement is calculated by adding basal metabolic rate (BMR) with additional energy from physical activity. Different composition of protein, carbohydrate and fat were given to each arm depends on their group. After 4 hours, participants were given ad libitum meal. After the participants done eating, the calorie in meal taken by participants was measured. |
|
EXPERIMENTAL: Low Protein
(12.4% protein)
|
Participants should not eat within the last 10 hours. Participants could drink mineral water up to 2 hours before intervention. Breakfast given is a milk-based formula which has to be finished within 15 minutes, and subjects could only consume 600 mL of mineral water within the next 4 hours after intervention. Participants' blood was taken before intervention, and 15, 60, 120, and 180 minutes after intervention, then examined in laboratory to measure ghrelin and PYY level. Breakfast given is adjusted to participants' energy requirement. Energy requirement is calculated by adding basal metabolic rate (BMR) with additional energy from physical activity. Different composition of protein, carbohydrate and fat were given to each arm depends on their group. After 4 hours, participants were given ad libitum meal. After the participants done eating, the calorie in meal taken by participants was measured. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ghrelin levels at 0 minute
Time Frame: baseline
|
analyzed by ELISA, directly taken after having the breakfast with different protein composition
|
baseline
|
|
Ghrelin levels at 15 minute
Time Frame: 15 minutes
|
analyzed by ELISA, taken 15 minutes after having the breakfast with different protein composition
|
15 minutes
|
|
Ghrelin levels at 60 minute
Time Frame: 60 minutes
|
analyzed by ELISA, taken 60 minutes after having the breakfast with different protein composition
|
60 minutes
|
|
Ghrelin levels at 120 minute
Time Frame: 120 minutes
|
analyzed by ELISA, taken 60 minutes after having the breakfast with different protein composition
|
120 minutes
|
|
Ghrelin levels at 180 minute
Time Frame: 180 minutes
|
analyzed by ELISA, taken 60 minutes after having the breakfast with different protein composition
|
180 minutes
|
|
PYY levels at 0 minute
Time Frame: baseline
|
analyzed by Radioimmunoassay, directly taken after having the breakfast with different protein composition
|
baseline
|
|
PYY levels at 15 minute
Time Frame: 15 minutes
|
analyzed by Radioimmunoassay, taken 15 minutes after having the breakfast with different protein composition
|
15 minutes
|
|
PYY levels at 60 minute
Time Frame: 60 minutes
|
analyzed by Radioimmunoassay, taken 60 minutes after having the breakfast with different protein composition
|
60 minutes
|
|
PYY levels at 120 minute
Time Frame: 120 minutes
|
analyzed by Radioimmunoassay, taken 120 minutes after having the breakfast with different protein composition
|
120 minutes
|
|
PYY levels at 180 minute
Time Frame: 180 minutes
|
analyzed by Radioimmunoassay, taken 180 minutes after having the breakfast with different protein composition
|
180 minutes
|
|
GLP-1 levels at 0 minute
Time Frame: baseline
|
analyzed by ELISA, directly taken after having the breakfast with different protein composition
|
baseline
|
|
GLP-1 levels at 15 minute
Time Frame: 15 minutes
|
analyzed by ELISA, taken 15 minutes after having the breakfast with different protein composition
|
15 minutes
|
|
GLP-1 levels at 60 minute
Time Frame: 60 minutes
|
analyzed by ELISA, taken 60 minutes after having the breakfast with different protein composition
|
60 minutes
|
|
GLP-1 levels at 120 minute
Time Frame: 120 minutes
|
analyzed by ELISA, taken 120 minutes after having the breakfast with different protein composition
|
120 minutes
|
|
GLP-1 levels at 180 minute
Time Frame: 180 minutes
|
analyzed by ELISA, taken 180 minutes after having the breakfast with different protein composition
|
180 minutes
|
|
Glucose levels at 0 minute
Time Frame: baseline
|
analyzed by standard random glucose level from venous blood, taken directly after having the breakfast with different protein composition
|
baseline
|
|
Glucose levels at 15 minute
Time Frame: 15 minutes
|
analyzed by standard random glucose level from venous blood, taken 15 minutes after having the breakfast with different protein composition
|
15 minutes
|
|
Glucose levels at 60 minute
Time Frame: 60 minutes
|
analyzed by standard random glucose level from venous blood, taken 60 minutes after having the breakfast with different protein composition
|
60 minutes
|
|
Glucose levels at 120 minute
Time Frame: 120 minutes
|
analyzed by standard random glucose level from venous blood, taken 120 minutes after having the breakfast with different protein composition
|
120 minutes
|
|
Glucose levels at 180 minute
Time Frame: 180 minutes
|
analyzed by standard random glucose level from venous blood, taken 180 minutes after having the breakfast with different protein composition
|
180 minutes
|
|
Ad Libitum intake
Time Frame: 4 hours
|
Mean Ad Libitum intake (calories) in subjects four hours after breakfast with different protein composition
|
4 hours
|
|
VAS for hunger at 0 minutes
Time Frame: baseline
|
Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level).
Extreme choices are both ends of the straight line.
The minimum value is at the left end and the maximum value is at the right end.
The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), directly taken after having the breakfast with different protein composition
|
baseline
|
|
VAS for hunger at 15 minutes
Time Frame: 15 minutes
|
Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level).
Extreme choices are both ends of the straight line.
The minimum value is at the left end and the maximum value is at the right end.
The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 15 minutes after having the breakfast with different protein composition
|
15 minutes
|
|
VAS for hunger at 60 minutes
Time Frame: 60 minutes
|
Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level).
Extreme choices are both ends of the straight line.
The minimum value is at the left end and the maximum value is at the right end.
The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 60 minutes after having the breakfast with different protein composition
|
60 minutes
|
|
VAS for hunger at 120 minutes
Time Frame: 120 minutes
|
Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level).
Extreme choices are both ends of the straight line.
The minimum value is at the left end and the maximum value is at the right end.
The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 120 minutes after having the breakfast with different protein composition
|
120 minutes
|
|
VAS for hunger at 180 minutes
Time Frame: 180 minutes
|
Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level).
Extreme choices are both ends of the straight line.
The minimum value is at the left end and the maximum value is at the right end.
The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 180 minutes after having the breakfast with different protein composition
|
180 minutes
|
|
VAS for satiety at 0 minute
Time Frame: baseline
|
Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level).
Extreme choices are both ends of the straight line.
The minimum value is at the left end and the maximum value is at the right end.
The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken directly after having the breakfast with different protein composition
|
baseline
|
|
VAS for satiety at 15 minute
Time Frame: 15 minutes
|
Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level).
Extreme choices are both ends of the straight line.
The minimum value is at the left end and the maximum value is at the right end.
The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 15 minutes after having the breakfast with different protein composition
|
15 minutes
|
|
VAS for satiety at 60 minute
Time Frame: 60 minutes
|
Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level).
Extreme choices are both ends of the straight line.
The minimum value is at the left end and the maximum value is at the right end.
The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 60 minutes after having the breakfast with different protein composition
|
60 minutes
|
|
VAS for satiety at 120 minute
Time Frame: 120 minutes
|
Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level).
Extreme choices are both ends of the straight line.
The minimum value is at the left end and the maximum value is at the right end.
The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 120 minutes after having the breakfast with different protein composition
|
120 minutes
|
|
VAS for satiety at 180 minute
Time Frame: 180 minutes
|
Visual Analog Scale, a scale in the form of an empty straight line with no values but only several level point (ex: if the line is 10cm, then each cm represent 1 level).
Extreme choices are both ends of the straight line.
The minimum value is at the left end and the maximum value is at the right end.
The subject must make a choice between the two ends of the line by giving an X mark (ex : if the subject feels less hunger, then the subject should mark X at the second point from far left), taken 180 minutes after having the breakfast with different protein composition
|
180 minutes
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GuthormonesS3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on diet with different composition
-
David BaerNational Institute on Deafness and Other Communication Disorders (NIDCD); Monell...Active, not recruiting
-
University of BirminghamLucozade Ribena SuntoryCompletedDietary ManipulationUnited Kingdom
-
Indonesia UniversityCompleted
-
German Institute of Human NutritionCharite University, Berlin, Germany; Helmholtz Center Munich; Hasso Plattner...RecruitingObesity | Overweight | Type 2 Diabetes | PrediabetesGermany
-
Jorge BondiaMinisterio de Economía y Competitividad, Spain; Hospital Francesc de Borja,...CompletedDiabetes Mellitus, Type 1Spain
-
The Cleveland ClinicNestléCompletedObesity | Overweight | Pre-diabeticUnited States
-
Stanford UniversityCompleted
-
Nigde Omer Halisdemir UniversityAcibadem UniversityRecruitingMultiple Sclerosis | Intermittent FastingTurkey
-
Boston Children's HospitalBrigham and Women's Hospital; Boston Medical Center; Nutrition Science Initiative and other collaboratorsCompleted
-
University of AlicanteNot yet recruiting